Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Rectal Neoplasms. Found 14 abstracts

Meyer JE, Cohen SJ, Ruth KJ, Sigurdson ER, Hall MJ. Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer. Journal of the National Cancer Institute. 2016 Jan;108(1).   PMCID: PMC4715232
Marks EI, Brennan M, El-Deiry WS. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. Cancer Biology & Therapy. 2015 Aug;16(8):1136-9.   PMCID: 4622690
Porpiglia AS, Sigurdson ER. Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers. Current treatment options in oncology. 2015 Sep;16(9):46.
Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. International Journal of Radiation Oncology Biology Physics. 2015 Jan;91(1):116-23.   PMCID: 4385459
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Konski A, Li T, Sigurdson E, Cohen SJ, Small W, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys. 2009 May;74(1):55-9.   PMCID: PMC2933375
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP. Rectal cancer. J Natl Compr Canc Netw. 2007 Oct;5(9):940-81.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Rectal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):492-508.
Newschaffer CJ, Topham A, Herzberg T, Weiner S, Weinberg DS. Risk of colorectal cancer after breast cancer. Lancet (London, England). 2001 Mar 17;357(9259):837-40.
Chao C, Goldberg M, Hoffman JP. Surgical salvage therapy: abdominoperineal resection for recurrent anal carcinoma, metastasectomy of recurrent colorectal cancer, and esophagectomy after combined chemoradiation. Curr Opin Oncol. 2000 Jul;12(4):353-6.
Sasson AR, Sigurdson ER. Management of locally advanced rectal cancer. Surgical oncology. 2000 Dec;9(4):193-204.
Simunovic M, To T, Baxter N, Balshem A, Ross E, Cohen Z, McLeod R, Engstrom P, Sigurdson E. Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population. J Gastrointest Surg. 2000 May;4(3):324-30.
Le Voyer TE, Hoffman JP, Cooper H, Ross E, Sigurdson E, Eisenberg B. Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment. Am Surg. 1999 Jul;65(7):625-30; discussion 630-1.
Johnson DE, Hoffman JP. Sphincter preservation in rectal cancer. Surgical considerations for local excision. Semin Radiat Oncol. 1998 Jan;8(1):39-47.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Rectal Neoplasms

Rectal Neoplasms pathology surgery Neoplasm Staging Human Adjuvant Radiotherapy therapy Male Aged Female Adjuvant Chemotherapy Adenocarcinoma radiotherapy Fluorouracil Antineoplastic Combined Chemotherapy Protocols Adult drug therapy mortality Neoadjuvant Therapy diagnosis Organoplatinum Compounds Risk Factors Survival Analysis Middle Age Middle Aged therapeutic use Leucovorin Lymph Node Excision Rectum Logistic Models 80 and over Aged Abdomen Colorectal Neoplasms Local Neoplasm Recurrence Perineum Lymphatic Metastasis methods Camptothecin Colonic Neoplasms Salvage Therapy Deoxycytidine statistics & numerical data Liver Neoplasms Squamous Cell Carcinoma Treatment Outcome Age Factors epidemiology Survival Rate Radiosurgery Cohort Studies Smooth Muscle Prognosis Anus 7689-03-4 (Camptothecin) statistics & numerical Antineoplastic Agents Intestinal Mucosa derivatives United States Odds Ratio Patient Selection Gastrointestinal Endoscopy Esophageal Neoplasms data Carcinoembryonic Antigen Poisson Distribution administration & Postoperative Complications Lung Neoplasms metabolism Anus Neoplasms di [Diagnosis] 0 (Antineoplastic Combined Chemotherapy Protocols) 0 (Organoplatinum Compounds) 58-05-9 (Leucovorin) analogs & classification Quality of Health Care Proctoscopy 0 (Folfox protocol) tumor marker physiology Colostomy 51-21-8 (Fluorouracil) anatomy & histology Chemoradiotherapy Databases Ca 19-9 su [Surgery] Microsurgery CA-19-9 Antigen blood Multivariate Analysis Endoscopy diagnostic use aa [Analogs & Derivatives] Breast Neoplasms Fluorodeoxyglucose F18 pharmacokinetics Mitomycin Disease-Free Survival Physician's Practice Patterns radionuclide imaging utilization Early Detection of Cancer st [Standards] Radiation-Sensitizing Agents Nonparametric Statistics Medical Oncology administration & dosage Use] 0 (IFL protocol) SEER Program Radiopharmaceuticals tu [Therapeutic Use] Data Collection Pelvic Exenteration Risk Assessment Capecitabine Positron-Emission Tomography sc [Secondary] Digestive System Surgical Procedures Tumor Biomarkers dosage Phase II Clinical Trials rt [Radiotherapy] Teaching Hospitals Esophagectomy Drug Administration Schedule Fecal Incontinence Ontario etiology analogs & derivatives dt [Drug Therapy] Analysis of Variance Combined Modality Therapy complications Radiotherapy Dosage metastatic colorectal adenocarcinoma Population Surveillance tu [Therapeutic Restorative Proctocolectomy Cea Lymph Nodes Retrospective Studies
Last updated on Thursday, April 02, 2020